Clonal relatedness between lobular carcinoma in situ and synchronous malignant lesions.
MRI for breast cancer screening, diagnosis, and treatment.
Lancet., Nov;378(9805):1804-11 (2011)
Cadherin-catenin complex dissociation in lobular neoplasia of the breast.
Breast Cancer Res. Treat., Apr;132(2):641-52 (2012)
The evolution of the locoregional therapy of breast cancer.
Oncologist., 16(10):1367-79 (2011)
Radiation field design and regional control in sentinel lymph node-positive breast cancer patients with omission of axillary dissection.
Cancer., Apr;118(8):1994-2003 (2012)
Differentially expressed genes in window trials are influenced by the wound-healing process: lessons learned from a pilot study with anastrozole.
J. Surg. Res., Jul;176(1):121-32 (2012)
Clinical management factors contribute to the decision for contralateral prophylactic mastectomy.
J. Clin. Oncol., Jun;29(16):2158-64 (2011)
Occult malignancy in patients undergoing contralateral prophylactic mastectomy.
Ann. Surg., Jul;254(1):2-7 (2011)
Prophylactic mastectomy of the contralateral breast.
Breast., Oct;20 Suppl 3:S108-10 (2011)
A prospective evaluation of the durability of palliative interventions for patients with metastatic breast cancer.
Cancer., Jul;116(14):3338-47 (2010)
Determinants of outcome in elderly patients with positive sentinel lymph nodes.
Am. J. Surg., Jun;201(6):734-40 (2011)
Magnetic resonance imaging for screening, diagnosis, and eligibility for breast-conserving surgery: promises and pitfalls.
Surg. Oncol. Clin. N. Am., Jul;19(3):475-92 (2010)
The clinical impact and outcomes of immunohistochemistry-only metastasis in breast cancer.
Am. J. Surg., Sep;200(3):368-73 (2010)
Trends in the surgical treatment of breast cancer.
Breast J., 16 Suppl 1:S17-9 (2010)
Randomized clinical trials in breast cancer.
Surg. Oncol. Clin. N. Am., Jan;19(1):33-58 (2010)
Number of lymph nodes removed in sentinel lymph node-negative breast cancer patients is significantly related to patient age and tumor size: a new source of bias in morbidity assessment?
Cancer., Apr;116(8):1987-91 (2010)
A clinical oncologic perspective on breast magnetic resonance imaging.
Magn Reson Imaging Clin N Am., May;18(2):277-94, ix (2010)
How much can improved molecular and pathologic discriminants change local therapy?
Breast Cancer Res., 10 Suppl 4:S5 (2008)
The evolving role of axillary dissection.
Clin Adv Hematol Oncol., Mar;7(3):167-8 (2009)
Surgeon recommendations and receipt of mastectomy for treatment of breast cancer.
JAMA., Oct;302(14):1551-6 (2009)